Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP
Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP

Will Malaysia dropping AstraZeneca from main inoculation drive fuel vaccine hesitancy?

  • Only China’s Sinovac Biotech vaccine and Pfizer-BioNTech shot now offered at government vaccination centres, but AstraZeneca jab is still available as an opt-in
  • Experts say this allays public concerns over side-effects like blood clots; others say it may damage trust in vaccines and undermine global vaccination efforts

Topic |   Coronavirus pandemic
Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP
Analysts say Malaysia and other countries need to balance the risks associated with vaccines such as AstraZeneca’s against the much larger threat of the Covid-19 pandemic. Photo: AP
READ FULL ARTICLE